Skip to main content
Erschienen in: Pituitary 4/2010

01.12.2010

Radiotherapy in paediatric Cushing’s disease: efficacy and long term follow up of pituitary function

verfasst von: Shrikrishna V. Acharya, Raju A. Gopal, Joe Goerge, Padma S. Menon, Tushar R. Bandgar, Nalini S. Shah

Erschienen in: Pituitary | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Pituitary radiotherapy (RT) is an effective second-line treatment for paediatric Cushing’s disease (CD). We report long-term efficacy and anterior pituitary function in a cohort of paediatric CD patients treated with RT. Between 1988 and 2008, from our cohort of 48 paediatric CD patients, eight paediatric CD patients (5 males and 3 females) underwent second-line pituitary RT (45 Gy in 25 fractions), following unsuccessful transsphenoidal surgery. Out of eight whose long term follow up is available, four patients were cured by RT. Minimum follow up of 2 years is available for all patients. Four patients achieved cure after RT. Two patients were not cured even after follow up of 60 and 132 months, respectively. Out of four uncured patients, two of them had suppressible low dose dexamethasone cortisol with altered circadian rhythm suggesting possibility of response in near future with follow up of just 26 months. Five patients were hypogonadal and one patient was hypothyroid. All patients were below their target height at the time of last follow up. None of the patients had posterior pituitary dysfunction. This series of patients illustrates the efficacy and long-term follow up of pituitary function in children with CD treated with RT. This study also emphasizes the need of growth hormone statues assessment and timely intervention.
Literatur
1.
Zurück zum Zitat Savage MO, Besser GM (1996) Cushing’s disease in childhood. Trends Endocrinol Metab 7:213–216CrossRefPubMed Savage MO, Besser GM (1996) Cushing’s disease in childhood. Trends Endocrinol Metab 7:213–216CrossRefPubMed
2.
Zurück zum Zitat Weber A, Trainer PJ, Grossman AB, Afshar F, Medbak S, Perry LA, Plowman PN, Ress LH, Besser GM, Savage MO (1995) Investigation, management and therapeutic outcome in 12 cases of childhood and adolescent Cushing’s syndrome. Clin Endocrinol 43:19–28CrossRef Weber A, Trainer PJ, Grossman AB, Afshar F, Medbak S, Perry LA, Plowman PN, Ress LH, Besser GM, Savage MO (1995) Investigation, management and therapeutic outcome in 12 cases of childhood and adolescent Cushing’s syndrome. Clin Endocrinol 43:19–28CrossRef
3.
Zurück zum Zitat Magiakou MA, Mastorakos G, Oldfield EH, Gomez MT, Doppman JL, Cutler GB Jr, Nieman LK, Chrousos GP (1994) Cushing’s syndrome in children and adolescents. Presentation, diagnosis, and therapy. N Engl J Med 31:629–636CrossRef Magiakou MA, Mastorakos G, Oldfield EH, Gomez MT, Doppman JL, Cutler GB Jr, Nieman LK, Chrousos GP (1994) Cushing’s syndrome in children and adolescents. Presentation, diagnosis, and therapy. N Engl J Med 31:629–636CrossRef
4.
Zurück zum Zitat Storr HL, Isidori AM, Monson JP, Besser GM, Grossman AB, Savage MO (2004) Prepubertal Cushing’s disease is more common in males, but there is no increase in severity at diagnosis. J Clin Endocrinol Metab 89:3818–3820CrossRefPubMed Storr HL, Isidori AM, Monson JP, Besser GM, Grossman AB, Savage MO (2004) Prepubertal Cushing’s disease is more common in males, but there is no increase in severity at diagnosis. J Clin Endocrinol Metab 89:3818–3820CrossRefPubMed
5.
Zurück zum Zitat Newell-Price J, Bertagna X, Grossman AB, Nieman LK (2006) Cushing’s syndrome. Lancet 367:1605–1617CrossRefPubMed Newell-Price J, Bertagna X, Grossman AB, Nieman LK (2006) Cushing’s syndrome. Lancet 367:1605–1617CrossRefPubMed
6.
Zurück zum Zitat Greening JE, Brain CE, Perry LA, Mushtaq I, Sales MJ, Grossman AB, Savage MO (2005) Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing’s disease. Horm Res 64:140–143CrossRefPubMed Greening JE, Brain CE, Perry LA, Mushtaq I, Sales MJ, Grossman AB, Savage MO (2005) Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing’s disease. Horm Res 64:140–143CrossRefPubMed
7.
Zurück zum Zitat Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Niemann LK, Sonino N, Vance ML, Giustina A, Boscaro M (2003) Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593–5602CrossRefPubMed Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Niemann LK, Sonino N, Vance ML, Giustina A, Boscaro M (2003) Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593–5602CrossRefPubMed
8.
Zurück zum Zitat Devoe DJ, Miller WL, Conte FA, Kaplan SL, Grumbach MM, Rosenthal SM, Wilson CB, Gitelman SE (1997) Long-term outcome in children and adolescents after transsphenoidal surgery for Cushing’s disease. J Clin Endocrinol Metab 82:3196–3202CrossRefPubMed Devoe DJ, Miller WL, Conte FA, Kaplan SL, Grumbach MM, Rosenthal SM, Wilson CB, Gitelman SE (1997) Long-term outcome in children and adolescents after transsphenoidal surgery for Cushing’s disease. J Clin Endocrinol Metab 82:3196–3202CrossRefPubMed
9.
Zurück zum Zitat Knappe UJ, Ludecke DK (1996) Transnasal microsurgery in children and adolescents with Cushing’s disease. Neurosurgery 39:484–492CrossRefPubMed Knappe UJ, Ludecke DK (1996) Transnasal microsurgery in children and adolescents with Cushing’s disease. Neurosurgery 39:484–492CrossRefPubMed
10.
Zurück zum Zitat Leinung MC, Kane LA, Scheithauer BW, Carpenter PC, Laws ER Jr, Zimmerman D (1995) Long term follow-up of transsphenoidal surgery for the treatment of Cushing’s disease in childhood. J Clin Endocrinol Metab 80:2475–2479CrossRefPubMed Leinung MC, Kane LA, Scheithauer BW, Carpenter PC, Laws ER Jr, Zimmerman D (1995) Long term follow-up of transsphenoidal surgery for the treatment of Cushing’s disease in childhood. J Clin Endocrinol Metab 80:2475–2479CrossRefPubMed
11.
Zurück zum Zitat Storr HL, Plowman PN, Carroll PV, Francois I, Krassas GE, Afshar F, Besser GM, Grossman AB, Savage MO (2003) Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing’s disease: an effective second-line treatment. J Clin Endocrinol Metab 88:34–37CrossRefPubMed Storr HL, Plowman PN, Carroll PV, Francois I, Krassas GE, Afshar F, Besser GM, Grossman AB, Savage MO (2003) Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing’s disease: an effective second-line treatment. J Clin Endocrinol Metab 88:34–37CrossRefPubMed
12.
Zurück zum Zitat Chan LF, Storr HL, Plowman PN, Perry LA, Besser GM, Grossman AB, Savage MO (2007) Long-term anterior pituitary function in patients with paediatric Cushing’s disease treated with pituitary radiotherapy. Eur J Endocrinol 156:477–482CrossRefPubMed Chan LF, Storr HL, Plowman PN, Perry LA, Besser GM, Grossman AB, Savage MO (2007) Long-term anterior pituitary function in patients with paediatric Cushing’s disease treated with pituitary radiotherapy. Eur J Endocrinol 156:477–482CrossRefPubMed
13.
Zurück zum Zitat John M, Lila AR, Bandgar T, Menon PS, Shah NS (2009) Diagnostic efficacy of serum midnight cortisol and midnight ACTH in the diagnosis and localization of cushing’s syndrome: Ahead of print; E-pub; Pituitary doi: 10.1007/s11102-009-0197-8 John M, Lila AR, Bandgar T, Menon PS, Shah NS (2009) Diagnostic efficacy of serum midnight cortisol and midnight ACTH in the diagnosis and localization of cushing’s syndrome: Ahead of print; E-pub; Pituitary doi: 10.​1007/​s11102-009-0197-8
14.
Zurück zum Zitat Jennings AS, Liddle GW, Orth DN (1977) Results of treating childhood Cushing’s disease with pituitary irradiation. N Engl J Med 297:957–962CrossRefPubMed Jennings AS, Liddle GW, Orth DN (1977) Results of treating childhood Cushing’s disease with pituitary irradiation. N Engl J Med 297:957–962CrossRefPubMed
15.
Zurück zum Zitat Savage MO, Lienhardt A, Lebrethon MC, Johnston LB, Huebner A, Grossman AB, Lesage J, Lafontaine L, Lacroix A (2001) Cushing’s disease in childhood: presentation, investigation, treatment and long-term outcome. Horm Res 55:24–30CrossRefPubMed Savage MO, Lienhardt A, Lebrethon MC, Johnston LB, Huebner A, Grossman AB, Lesage J, Lafontaine L, Lacroix A (2001) Cushing’s disease in childhood: presentation, investigation, treatment and long-term outcome. Horm Res 55:24–30CrossRefPubMed
16.
Zurück zum Zitat Thoren M, Rahn T, Hallengren B, Kaad PH, Nilsson KO, Ravn H, Ritzen M, Petersen KE, Aarskog D (1986) Treatment of Cushing’s disease in childhood and adolescence by stereotactic pituitary irradiation. Acta Pædiatr Scand 75:388–395CrossRefPubMed Thoren M, Rahn T, Hallengren B, Kaad PH, Nilsson KO, Ravn H, Ritzen M, Petersen KE, Aarskog D (1986) Treatment of Cushing’s disease in childhood and adolescence by stereotactic pituitary irradiation. Acta Pædiatr Scand 75:388–395CrossRefPubMed
17.
Zurück zum Zitat Estrada J, Boronat M, Mielgo M, Magallon R, Millan I, Diez S, Lucas T, Barcelo B (1997) The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing’s disease. N Engl J Med 336:172–177CrossRefPubMed Estrada J, Boronat M, Mielgo M, Magallon R, Millan I, Diez S, Lucas T, Barcelo B (1997) The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing’s disease. N Engl J Med 336:172–177CrossRefPubMed
18.
Zurück zum Zitat Zierhut D, Flentje M, Adolph J, Erdmann J, Raue F, Wannenmacher M (1995) External radiotherapy of pituitary adenomas. Int J Radiat Oncol Biol Phys 33:307–314PubMed Zierhut D, Flentje M, Adolph J, Erdmann J, Raue F, Wannenmacher M (1995) External radiotherapy of pituitary adenomas. Int J Radiat Oncol Biol Phys 33:307–314PubMed
19.
Zurück zum Zitat Howlett TA, Plowman PN, Wass JA, Rees LH, Jones AE, Besser GM (1989) Megavoltage pituitary irradiation in the management of Cushing’s disease and Nelson’s syndrome: long-term follow-up. Clin Endocrinol 31:309–323CrossRef Howlett TA, Plowman PN, Wass JA, Rees LH, Jones AE, Besser GM (1989) Megavoltage pituitary irradiation in the management of Cushing’s disease and Nelson’s syndrome: long-term follow-up. Clin Endocrinol 31:309–323CrossRef
20.
Zurück zum Zitat Plowman PN (1999) Pituitary adenoma radiotherapy-when, who and how? Clin Endocrinol 51:265–271CrossRef Plowman PN (1999) Pituitary adenoma radiotherapy-when, who and how? Clin Endocrinol 51:265–271CrossRef
21.
Zurück zum Zitat Hughes NR, Lissett CA, Shalet SM (1999) Growth hormone status following treatment for Cushing’s syndrome. Clin Endocrinol 51:61–66CrossRef Hughes NR, Lissett CA, Shalet SM (1999) Growth hormone status following treatment for Cushing’s syndrome. Clin Endocrinol 51:61–66CrossRef
22.
Zurück zum Zitat Grossman A, Cohen BL, Charlesworth M, Plowman PN, Rees LH, Wass JAH, Jones AE, Besser GM (1984) Treatment of prolactinomas with megavoltage radiotherapy. Br Med J 288:1105–1109CrossRef Grossman A, Cohen BL, Charlesworth M, Plowman PN, Rees LH, Wass JAH, Jones AE, Besser GM (1984) Treatment of prolactinomas with megavoltage radiotherapy. Br Med J 288:1105–1109CrossRef
23.
Zurück zum Zitat Lebrethon MC, Grossman AB, Afshar F, Plowman PN, Besser GM, Savage MO (2000) Linear growth and final height after treatment for Cushing’s disease in childhood. J Clin Endocrinol Metab 85:3262–3265CrossRefPubMed Lebrethon MC, Grossman AB, Afshar F, Plowman PN, Besser GM, Savage MO (2000) Linear growth and final height after treatment for Cushing’s disease in childhood. J Clin Endocrinol Metab 85:3262–3265CrossRefPubMed
24.
Zurück zum Zitat Carroll PV, Monson JP, Grossman AB, Besser GM, Plowman PN, Afshar F, Savage MO (2004) Successful treatment of childhood-onset Cushing’s disease is associated with persistent reduction in growth hormone secretion. Clin Endocrinol 60:169–174CrossRef Carroll PV, Monson JP, Grossman AB, Besser GM, Plowman PN, Afshar F, Savage MO (2004) Successful treatment of childhood-onset Cushing’s disease is associated with persistent reduction in growth hormone secretion. Clin Endocrinol 60:169–174CrossRef
25.
Zurück zum Zitat Nicholl RM, Kirk JM, Grossman AB, Plowman PN, Besser GM, Savage MO (1993) Acceleration of pubertal development following pituitary radiotherapy for Cushing’s disease. Clin Oncol 5:393–394CrossRef Nicholl RM, Kirk JM, Grossman AB, Plowman PN, Besser GM, Savage MO (1993) Acceleration of pubertal development following pituitary radiotherapy for Cushing’s disease. Clin Oncol 5:393–394CrossRef
26.
Zurück zum Zitat (2004) Disorders of the anterior pituitary. In: Warrell DA, Cox TM, Firth JD, Benz EJ Jr (eds) Oxford textbook of medicine, ch 12, 4th edn. Oxford University Press, Oxford (2004) Disorders of the anterior pituitary. In: Warrell DA, Cox TM, Firth JD, Benz EJ Jr (eds) Oxford textbook of medicine, ch 12, 4th edn. Oxford University Press, Oxford
Metadaten
Titel
Radiotherapy in paediatric Cushing’s disease: efficacy and long term follow up of pituitary function
verfasst von
Shrikrishna V. Acharya
Raju A. Gopal
Joe Goerge
Padma S. Menon
Tushar R. Bandgar
Nalini S. Shah
Publikationsdatum
01.12.2010
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 4/2010
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-010-0231-x

Weitere Artikel der Ausgabe 4/2010

Pituitary 4/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.